1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics in Italy, May 2020

Cancer Analysis & Statistics in Italy, May 2020

1-30 of about 200 reports

2020 Italy Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 570 pages

2020 Italy Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers H ...

  • Cancer
  • Italy
  • Demand

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted EGFR-NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Italy
  • United States

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Italy
  • United States

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Italy
  • United Kingdom

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Italy
  • United Kingdom

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Anaplastic lymphoma kinase-Non Small Cell Lung Cancer (ALK-NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted ALK NSCLCepidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • Italy

2020 Italy Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 525 pages

2020 Italy Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities This new report ...

  • Cancer
  • Pathology
  • Italy
  • Demand

2020 Italy Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 525 pages

2020 Italy Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains ...

  • Cancer
  • Pathology
  • Italy
  • Forecast

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - Epidemiology Forecast - 2030

  • $ 3750
  • April 2020
  • 72 pages

‘Blastic plasmacytoid dendritic cell neoplasm (BPDCN) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPDCN, historical and forecasted epidemiology in the United ...

  • Biopharmaceutical
  • Cancer
  • Cell Therapy
  • Medical Biotechnology
  • Italy

2020 Italy Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 570 pages

2020 Italy Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • Italy
  • Demand

Italy Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 525 pages

Italy Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 525 pages, 38 tables, and ...

  • Cancer
  • Italy

Italy Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 525 pages

Italy Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 525 ...

  • Cancer
  • Italy
  • Forecast

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Cancer
  • Pathology
  • Italy
  • United Kingdom
  • Demand

Italy Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 570 pages

Italy Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • Italy
  • Demand

Italy Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 2450
  • July 2019
  • 570 pages

Italy Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023 HighlightsComprehensive ...

  • Cancer
  • Italy
  • Market Shares

Italy Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • May 2019
  • 525 pages

Italy Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities This new report from V ...

  • Cancer
  • Pathology
  • Italy
  • Demand

Italy Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 525 pages

Italy Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 525 pages, 38 tables, and presents ...

  • Cancer
  • Pathology
  • Italy
  • Demand

Italy Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 525 pages

Italy Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 525 pages, 38 tables, and presents ...

  • Cancer
  • Pathology
  • Italy
  • Demand

2019 Italy Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • April 2019
  • 570 pages

2019 Italy Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers HighlightsComprehensive 570-page ...

  • Cancer
  • Italy
  • Market Shares

Nerviano Medical Sciences Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 27 pages

Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs.The company’s pipeline products include anticancer compounds such as Danusertib, ...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Italy
  • Nerviano Medical Sciences Srl

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • September 2018
  • 162 pages

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU Summary Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, ...

  • Cancer
  • Italy
  • Bristol-Myers Squibb Company
  • Novartis AG
  • PROVENGE group

Analysis of Western European Molecular Imaging Market, Forecast to 2022

  • $ 4950
  • August 2018
  • 125 pages

Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve This study takes a look at the Western European molecular imaging industry.The ...

  • Cancer
  • CT Scan
  • Germany
  • Italy
  • Forecast

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025

  • $ 3995
  • November 2017
  • 47 pages

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025 Summary Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood ...

  • Cancer
  • Hospital
  • Leukemia
  • Italy
  • Forecast

EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2026

  • $ 3995
  • July 2017
  • 47 pages

EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2026 Summary Acute Myeloid Leukemia (AML), also known as myelogenous leukemia, acute myelocytic leukemia, or acute nonlymphocytic leukemia, ...

  • Cancer
  • Leukemia
  • Italy
  • United States
  • Forecast

Italy Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1050
  • May 2017
  • 53 pages

The proton therapy market in Italy is anticipated to grow at a CAGR of around 25% during the period 2017 – 2022. In Italy, there are 3 proton beam therapy centers, which considerably boosts their capacity ...

  • Cancer
  • CT Scan
  • Italy
  • Forecast
  • Market Size

Europe Proton Therapy Market & Forecast, Patients Treated at Proton Therapy Centers, Reimbursement Policy

  • $ 1700
  • April 2017
  • 138 pages

Europe Proton Therapy Market has a market potential of much more than US$ 10 Billion in 2016. In the year 2009 France used be have the highest proton therapy market share. But by 2012 Germany replaced ...

  • Cancer
  • Hospital
  • Italy
  • Northern Europe
  • Western Europe

Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast

  • $ 1150
  • March 2017
  • 50 pages

Proton Therapy Market in Italy would double by the end of 2021 from its market in 2016. There are currently three proton therapy centers in Italy that significantly increases their capacity to treat more ...

  • Cancer
  • Italy
  • Demand
  • Market Size
  • Varian Medical Systems, Inc.

Epiomic Epidemiology Series: Colorectal Cancer Forecast in 18 Major Markets 2017-2027

  • $ 4740
  • March 2017
  • 90 pages

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Colorectal Cancer in 18 Major Markets Colorectal Cancer (CRC) affects the colon and rectum, which are a part of the large intestine. ...

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Italy
  • Southern Europe

Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Small Cell Lung Cancer patients study in a new report ‘Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Europe
  • Italy

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Renal Cell Carcinoma patients study in a new report ‘Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Cancer
  • Pathology
  • Renal Cancer
  • Europe
  • Italy

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on